Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Cell and Gene Therapy, Biologics, Cancer
        How to improve cell counting processes for accurate cell characterization.
            May 14, 2024 -
            2 min read
          
          
         
      Disease Research
        High-content imaging system reveals secrets of tuberculosis.
            May 14, 2024 -
            2 min read
          
          
         
      Physiological Model Solutions, Disease Research, Infectious Diseases
        Visualizing SARS-CoV-2 interactions in 3D.
            May 14, 2024 -
            2 min read
          
          
         
      Disease Research, Infectious Diseases
        Rethinking how we prepare for the next pandemic.
            May 14, 2024 -
            3 min read
          
          
         
      Disease Research
        Not just a respiratory disease – the cardio-COVID link.
            May 14, 2024 -
            2 min read
          
          
         
      Disease Research
        New insights into lung cancer evolution could help researchers tackle tumor resistance.
            May 14, 2024 -
            2 min read
          
          
         
      Disease Research
        Epigenetic therapy shows promise as a companion for immunotherapy.
            May 14, 2024 -
            2 min read
          
          
         
       
      Disease Research, Neuroscience Research
        A new human neuronal cell model of huntington’s disease for in vitro screening.
            May 13, 2024 -
            1 min read
          
          
         
      Disease Research
        Definitive evidence of narcolepsy as an autoimmune disease.
            May 13, 2024 -
            1 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  